Retrospective analysis shows potential for GLP-1s to treat blood clots

Max Gelman

Senior Editor

SAN DIEGO — As researchers explore more potential benefits of GLP-1 medicines, a new retrospective study is suggesting the drug class’ potential to treat venous …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Retrospective analysis shows potential for GLP-1s to treat blood clots

Max Gelman

Senior Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Kevin Tang's Concentra tries to disrupt proposed Acelyrin-Alumis merger

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Merck KGaA tees up changes to leadership team; Ex-CVS Health CEO joins Thermo Fisher’s board

Roche no longer wants to be where ‘DNA sequencing goes to die’

Trump’s HHS defends drug price negotiations in Novartis suit

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ret­ro­spec­tive analy­sis shows po­ten­tial for GLP-1s to treat blood clots

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Retrospective analysis shows potential for GLP-1s to treat blood clots